@article{article, title  = {{Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.}},

 url = {{}},

 year = {{2013}},

 month = {{12}},

 author = {{Barrett-Lee P and Casbard A and Abraham J and Hood K and Coleman R and Simmonds P and Timmins H and Wheatley D and Grieve R and Griffiths G and Murray N}},

 doi = {{10.1016/S1470-2045(13)70539-4}},

 volume = {{15}},

 journal = {{Lancet Oncol}},

 issue = {{1}},

 pages = {{114-122}},

 note = {{Accessed on 2025/10/10}}}